Article
Exclusive: China in talks with Pfizer for generic COVID drug
Rating:
0.0
Views:
72
Likes:
1
Library:
1
China is in talks with Pfizer to secure a license that will allow domestic drugmakers to manufacture and distribute a generic version of the U.S. firm's COVID-19 antiviral drug Paxlovid in the country, sources say.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value